ConcertAI is a prominent provider of clinical artificial intelligence and real-world data products in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, the company has additional offices in several global locations, including Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. ConcertAI aims to enhance patient outcomes by utilizing real-world data, AI technologies, and scientific expertise.
The company offers a range of AI-driven solutions designed to optimize clinical trials and provide predictive insights. Key offerings include CARAai Technologies, which enhance research and clinical decision-making, and CancerLinQ, an initiative that delivers automated quality solutions and analytic services for oncology providers. Additionally, TeraRecon ...
ConcertAI is a prominent provider of clinical artificial intelligence and real-world data products in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, the company has additional offices in several global locations, including Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. ConcertAI aims to enhance patient outcomes by utilizing real-world data, AI technologies, and scientific expertise.
The company offers a range of AI-driven solutions designed to optimize clinical trials and provide predictive insights. Key offerings include CARAai Technologies, which enhance research and clinical decision-making, and CancerLinQ, an initiative that delivers automated quality solutions and analytic services for oncology providers. Additionally, TeraRecon provides advanced visualizations and AI decision support for radiological imaging, improving diagnostic capabilities. ConcertAI collaborates with over 46 biomedical innovators and 2,000 healthcare providers to support its mission of accelerating therapeutic innovations.
-
Number of Employees:
250-1000
-
Annual Revenue:
$100-250 Million